FreeObituary Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61 July 02, 2026Vol.52 No.26By Paul Goldberg
FreeTrials & Tribulations Is it time to re-assess the practice and practicality of screening colonoscopy?Modeling data in ACS guideline support greater use of noninvasive tests to ease system strain, save lives July 02, 2026Vol.52 No.26By Paul J. Limburg
FreeTrials & Tribulations More than 50 million Americans remain unscreened for colon cancerNew guidelines offer another option July 02, 2026Vol.52 No.26By AmirAli Talasaz
FreeObituary Joe Fraumeni, founder of molecular epidemiology, dies at 93“It’s hard to imagine a world without the presence of this gentle scientific giant.” June 26, 2026Vol.52 No.25By Stephen J. Chanock
FreeObituary Karen Huntsman’s vision gave shape to the Huntsman Cancer Institute June 26, 2026Vol.52 No.25By Bradley Cairns
FreeIn the Archives Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise June 26, 2026Vol.52 No.25By Sara Willa Ernst
FreeTrials & Tribulations Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy June 12, 2026Vol.52 No.23By Peter F. Garrett
Cancer History ProjectFreePodcast “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research HospitalIn a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process May 15, 2026Vol.52 No.19By Claire Marie Porter
Free Ukrainian oncologists press on in year four of wartime disruptionsAmid missiles and blackouts, “you cannot put your life on a pause forever.” April 03, 2026Vol.52 No.13By Sara Willa Ernst
FreeGuest Editorial FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters mostDraft guidance consolidates trial design updates for developers April 03, 2026Vol.52 No.13By Nicholas Richardson
